$RGC Potential Bagger healthcare Company - HOT ST
Post# of 21209
(Total Views: 149)
Posted On: 11/25/2022 8:45:35 AM
$RGC Potential Bagger healthcare Company - HOT STOCK -
Regencel Bioscience Holding is a R&D and Commercialize Healthcare company that focusses on treating ADHD, ASD and COVID-19 using Traditional Chinese Medicine (”TCM”) approach.
The company’s stock has seen rough days of being shorted by both short sellers and traders alike and the Company CEO has not taken this event without a stand. Mr Au, the CEO of Regencell has voiced out “Short and distort schemes used on our stock are negatively affecting our company. These schemes hurt our investors and patients, especially children and their families who are looking for a natural approach to treat attention hyperactivity disorder (“ADHD”), autism spectrum disorder (“ASD”) and COVID-19, and have the potential to disrupt our mission to help our patients.”
[https://www.morningstar.com/news/business-wire/20220516005531/regencell-bioscience-holdings-limited-announces-over-5-million-ordinary-share-purchases-by-ceo]
Mr Au took further response by buying back over 5 million ordinary shares to defend the company against these short sellers and has also announced that he will not be drawing salary nor bonus (<1$) until the company reaches $1 Billion USD.
Further stance were taken by the company’s directors and employees where stock options which were previously granted upon company IPO will be subjected to a lock-up of 6 months vesting period. The shares will be locked up until January 16, 2023.
Regencel Bioscience Holding is a R&D and Commercialize Healthcare company that focusses on treating ADHD, ASD and COVID-19 using Traditional Chinese Medicine (”TCM”) approach.
The company’s stock has seen rough days of being shorted by both short sellers and traders alike and the Company CEO has not taken this event without a stand. Mr Au, the CEO of Regencell has voiced out “Short and distort schemes used on our stock are negatively affecting our company. These schemes hurt our investors and patients, especially children and their families who are looking for a natural approach to treat attention hyperactivity disorder (“ADHD”), autism spectrum disorder (“ASD”) and COVID-19, and have the potential to disrupt our mission to help our patients.”
[https://www.morningstar.com/news/business-wire/20220516005531/regencell-bioscience-holdings-limited-announces-over-5-million-ordinary-share-purchases-by-ceo]
Mr Au took further response by buying back over 5 million ordinary shares to defend the company against these short sellers and has also announced that he will not be drawing salary nor bonus (<1$) until the company reaches $1 Billion USD.
Further stance were taken by the company’s directors and employees where stock options which were previously granted upon company IPO will be subjected to a lock-up of 6 months vesting period. The shares will be locked up until January 16, 2023.
(0)
(0)